8-K ·Filed Jul 8, 2026
8-K context-dependent: Items 5.02
Actionable Insight • Neutral
This board departure is routine and has no material impact on MGNX. No trading action warranted.
MGNX drugs
MGNX drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60Entry
$4.57
T+0 close · Jul 8, 2026 · via day close
Latest settled
−21.66%
T+60 · $3.58
Vs SPY
−23.30%
α at T+60
Horizons
All settled
through T+60
- T+0 · Jul 9 $4.57entry
- T+1 · 4mo ago −5.25%α −5.68% · $4.33
- T+5 · 4mo ago −9.85%α −9.72% · $4.12
- T+20 · 3mo ago −12.25%α −14.50% · $4.01
- T+60 · 7w ago −21.66%α −23.30% · $3.58
Price Chart
REPLAYWatch the reaction play outLoading chart...
How similar events traded
Executive Summary
Karen Ferrante, M.D. resigned from the board of MacroGenics for personal reasons, effective September 1, 2026. The departure is routine and not due to any disagreement with the company.
Key Facts
- Dr. Ferrante resigned for personal reasons, effective September 1, 2026.
- No disagreement with company operations or practices.
Financial Impact
Not specified
Market Snapshot
Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
62% bullish (13 analysts)
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001125345-26-000047 |
| Document: 0001125345-26-000047-index-headers.html | 0001125345-26-000047 |
| Document: 0001125345-26-000047-index.html | 0001125345-26-000047 |
| Document: 0001125345-26-000047.txt | 0001125345-26-000047 |
Track record
21 reports on MGNX
4 of 6 bullish or bearish reports moved the stock their way by T+60. Best: +130.41% at T+60 after the Feb 28, 2026 report. 8 of 9 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $2.22 Now $2.17 −2.25% settles Feb 12
- Nov 13, 20263d ago 8-K Neutral 4/10 Entry $2.31 Now $2.17 −6.06% settles Feb 12
- Nov 12, 20264d ago Press Release Bearish 5/10 Entry $2.20 Now $2.17 +1.36% settles Feb 11
- Nov 3, 202613d ago 3 Neutral 1/10 Entry $2.31 Now $2.17 −6.06% settles Feb 2
- Nov 3, 202613d ago 3 Neutral 1/10 Entry $2.31 Now $2.17 −6.06% settles Feb 2
- Nov 3, 202613d ago 8-K Neutral 2/10 Entry $2.31 Now $2.17 −6.06% settles Feb 2
- Oct 26, 202621d ago Press Release Bullish 6/10 Entry $2.19 Now $2.17 −0.91% settles Jan 22
- Oct 23, 202624d ago 8-K Bullish 7/10 Entry $2.19 Now $2.17 −0.91% settles Jan 22
- Oct 22, 202625d ago 144 Neutral 2/10 Entry $2.25 Now $2.17 −3.56% settles Jan 21
- Oct 15, 20264w ago Press Release Neutral 3/10 Entry $3.25 Now $2.17 −33.23% settles Jan 13
Showing 10 of 21
US Market Status
Market Closed · Opens in 6h 36m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers